Exabis Library
Welcome to the e-CCO Library!
P447: Seasonal variations in Vitamin D concentrations in a single-centre inflammatory bowel disease series
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P447: The impact of therapeutic drug monitoring during biosimilar infliximab switch in inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P447: Vedolizumab induces significantly higher endoscopic remission rates at week 16 in ulcerative colitis as compared to Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P448 Dose adjustment in patients with moderate-to-severe ulcerative colitis: results from the UNIFI maintenance study long-term extension
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P448: Biologic therapy and immunodulators are associated with decreased risk of cardiovascular events in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P448: Cannabis and cannabinoids for the treatment of inflammatory bowel disease: a systematic review and meta-analysis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P448: IBD nurse in patients’ health status assessment: data from a pilot study comparing ability of IBD nurse and gastroenterologist in using IBD clinical scores
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P448: Long term effectiveness of first-line infliximab treatment compared to conventional treatment in paediatric moderate-to-severe Crohn's disease – an update from the TISKids study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P448: Oral beclomethasone dipropionate as an add-on therapy and response prediction in Korean patients with ulcerative colitis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P448: Remission induction therapy with tacrolimus and biological combination therapy for severe ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P448: Safety of anti-TNF introduction following tuberculosis treatment in Inflammatory Bowel Disease patients in an endemic area
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P449 Systematic review with meta-analysis: risk of lymphoma associated with anti-tumour necrosis factor (TNF) agents in inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P449: Autologous fat graft injection for the treatment of perianal fistulas in Crohn’s disease: A systematic review and single-arm meta-analysis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P449: Cost Effectiveness of a Proactive Therapeutic Drug Monitoring Strategy in Patients with Inflammatory Bowel Disease Receiving Infliximab
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P449: Double assessment of ileal pouch-anal anastomosis before ileostomy reversal
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P449: Efficacy and safety of switching between originator and biosimilar infliximab in patients with inflammatory bowel disease in practical clinic: results to 6 months
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P449: Minimally invasive IPAA in UC: Preliminary results from a referral center
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P449: Patient support program for adalimumab-treated patients with Crohn's disease in Brazil: impact on patients' adherence and persistence
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P449: Selective depletion of LAG3+ cells in T-cell-driven inflammation: a randomised, double-blind, placebo-controlled, FTIH phase I/Ib clinical trial
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P450 Thioguanine and low dose thiopurines and allopurinol are both safe options after failure of conventional thiopurines: a comparative analysis of two multicentre cohorts
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM